Showing results (321-330 of 346) with videos related to
Sort By:
Pageof 35
Journal of Neuropathology and Experimental Neurology|May 3, 2018
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult GliomasSherise D Ferguson, Shouhao Zhou, Jason T Huse, et al.Parasitology|June 15, 2018
Anti-α-Gal antibodies detected by novel neoglycoproteins as a diagnostic tool for Old World cutaneous leishmaniasis caused by Leishmania majorKrishanthi S Subramaniam, Victoria Austin, Nathaniel S Schocker, et al.BMJ Open|March 7, 2020
Protocol for a longitudinal, prospective cohort study investigating the biology of uterine fibroids and endometriosis, and patients' quality of life: the FENOX studyThomas Theodor Tapmeier, Hannah Mohamed Nazri, Kavita S Subramaniam, et al.Frontiers in Health Services|August 8, 2025
Advancing sustainability in low-resource settings: development and validation of a sustainability tool for evidence-based interventions and programsChisom Obiezu-Umeh, Divya S Subramaniam, Ucheoma Nwaozuru, et al.Journal of Molecular Evolution|December 16, 2000
Phylogenomic analysis of the alpha proteasome gene family from early-diverging eukaryotesJ L Bouzat, L K McNeil, H M Robertson, et al.Molecular Psychiatry|September 17, 2014
DISC1 regulates trafficking and processing of APP and Aβ generationN Shahani, S Seshadri, H Jaaro-Peled, et al.Bioorganic Chemistry|November 9, 2021
Clickable, selective, and cell-permeable activity-based probe of human cathepsin B - Minimalistic approach for enhanced selectivityAshif I Bhuiyan, Pratikkumar Rathod, Sarbani Ghoshal, et al.Journal of Crohn'S & Colitis|April 18, 2019
Endoscopic Resections in Inflammatory Bowel Disease: A Multicentre European Outcomes StudyA Alkandari, S Thayalasekaran, M Bhandari, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 10, 2012
Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beamsS Subramaniam, S Thirumalaiswamy, C Srinivas, et al.The Lancet. Oncology|February 4, 2018
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 studyGiuseppe Giaccone, Chul Kim, Jillian Thompson, et al.Pageof 35